New infant vaccine tested to fight serious bacterial infection
NCT ID NCT02140047
Summary
This study tested a new vaccine called MT-2301 to protect healthy infants from Haemophilus influenzae type b (Hib), a bacteria that can cause serious infections like meningitis. The study involved 154 infants between 2 and 7 months old and compared the new vaccine to an existing one. Researchers measured the infants' immune responses and monitored for any safety issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILUS INFLUENZA TYPE B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Fukuoka, Fukuoka, Japan
Conditions
Explore the condition pages connected to this study.